Celastrol induces proteasomal degradation of FANCD 2 to sensitize lung cancer cells to DNA crosslinking agents-Reference-Cited by-同舟云学术

Celastrol induces proteasomal degradation of FANCD 2 to sensitize lung cancer cells to DNA crosslinking agents

Published:2015-05-26 Issue:7 Volume:106 Page:902-908
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Wang Gui‐Zhen¹²,Liu Yong‐Qiang¹,Cheng Xin¹,Zhou Guang‐Biao¹

Affiliation:

1. Division of Molecular Carcinogenesis and Targeted Therapy for Cancer State Key Laboratory of Biomembrane and Membrane Biotechnology Institute of Zoology Chinese Academy of Sciences BeijingChina

2. University of Chinese Academy of Sciences Beijing China

Funder

National Natural Science Foundation of China

The National Natural Science Funds of China for Distinguished Young Scholar

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12679

Reference46 articles.

1. World Health Organization.GLOBOCAN 2012. GLOBOCAN 2013. [Cited 24 Dec 2014.] Available from URL:http://globocaniarcfr/Pages/fact_sheets_canceraspx.

2. Global cancer statistics

3. Lung Cancer

4. Platinum drugs and DNA repair mechanisms in lung cancer;Bonanno L;Anticancer Res,2014

5. Molecular mechanisms of cisplatin resistance

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FANCD2 expression affects platinum response and further characteristics of high grade serous ovarian cancer in cells with different genetic backgrounds;Experimental and Molecular Pathology;2024-08

2. H2AX: A key player in DNA damage response and a promising target for cancer therapy;Biomedicine & Pharmacotherapy;2024-06

3. Identification of arnicolide C as a novel chemosensitizer to suppress mTOR/E2F1/FANCD2 axis in non‐small cell lung cancer;British Journal of Pharmacology;2023-12-13

4. Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Suppresses Ferroptosis in Non-Small Cell Lung Cancer via Stabilizing m6A Modification of Fanconi Anemia Group D2 Protein;Journal of Biomedical Nanotechnology;2023-08-01

5. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies;Biomedicine & Pharmacotherapy;2023-07